Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F1GGK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,426
Award facts
- Contract value 100% obligated
- $14,426.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $14,426.12 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation on January 15, 2026, with completion expected by January 16, 2026. This is a firm fixed-price, non-set-aside contract with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems, particularly military and veteran programs.
This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. The IDC encompasses a broad range of pharmaceutical products and medical supplies across multiple therapeutic domains, enabling the company to efficiently supply specialty medications, brand-name and generic drugs, vaccines, and related medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The brief timeline between award and completion suggests this is a routine pharmaceutical fulfillment under the established DLA Medical Supply Chain framework.
Quick answers
Who was awarded contract SPE2DR26F1GGK?
SPE2DR26F1GGK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F1GGK worth?
The government has obligated $14,426 on SPE2DR26F1GGK.
Is contract SPE2DR26F1GGK an order under another contract?
Yes. SPE2DR26F1GGK is a delivery order under SPE2DR25D2106, an indefinite delivery contract.
Was contract SPE2DR26F1GGK competed?
The extent of competition for SPE2DR26F1GGK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award